This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Infectious Diseases Molecular Diagnostics Market

With the Covid-19 outbreak, a sudden spurt in demand for infectious disease molecular diagnostics was observed: Significant opportunities projected post-pandemic

Infectious Disease Molecular Diagnostics Market by Technology, Product Type, Application, End User & Region - Forecast 2022 - 2032

Infectious Disease Molecular Diagnostics Market Outlook (2022-2032)

The global Infectious Disease Molecular Diagnostics Market was valued at around US$ 34 Bn in 2021. With a projected CAGR of 4.2% for the next ten years, the market is likely to reach a valuation of nearly US$ 53 Bn by the end of 2032. Developers are increasingly relying on scientific developments from a variety of fields rather than the traditional methods that required the culture of the pathogens. Molecular diagnostics is one of the fields in infectious Disease identification that is expanding the fastest.

Report Attributes

Details

Infectious Disease Molecular Diagnostics Market Size (2021A)

US$ 34.0 Bn

Estimated Market Value (2022E)

US$ 35 Bn

Forecasted Market Value (2032F)

US$ 53 Bn

Global Market Growth Rate (2022-2032)

4.2% CAGR

United States Growth Rate (2022-2032)

4.3% CAGR

Key Companies Covered

  • Abbott
  • Danaher Corporation
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc. (Gen-Probe)
  • Illumina, Inc.
  • Grifols S.A.
  • Qiagen
  • Siemens Healthineers AG
  • Sysmex Corporation
Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Infectious Disease Infectious Disease Molecular Diagnostics Market from 2017 to 2021 Vs Market Outlook for 2022 to 2032

The global market for the Infectious Disease Molecular Diagnostics Market expanded at a CAGR of 3.8% over the last four years (2017-2021). Future Market Insights’ analysis reveals that in 2022 revenue through the market is estimated at US$ 39.5 Bn. With an absolute dollar opportunity of US$ 18 Bn during 2022 – 2032, the market is projected to reach a valuation of US$ 53 Bn by 2032.

The United States will continue to be the largest consumer of the Infectious Disease Molecular Diagnostics Market throughout the analysis period accounting for over US$ 5.8 Bn absolute dollar opportunity in the coming 10-year period

What are the key drivers in Infectious Disease Molecular Diagnostics Market?

Global outbreaks of deadly infectious diseases caused by pathogenic microorganisms have threatened public health worldwide and significantly motivated researchers to develop rapid and accurate detection methods for pathogens. Culture-based techniques are considered gold standards for pathogen detection globally. However, the long result time associated with these techniques due to overnight culturing and limited pathogen isolation has slowed their demand to a certain extent. Over the past several years, innovations in molecular diagnostic technology and their use have fundamentally altered the ability to handle infectious diseases. It provides quicker and more reliable results at 30% less cost to the customers.

Although still in its infancy, pharmacogenomics has the potential to grow into a rich industry as demand for tailored medication rises. As the driving force behind the transition to personalized medicine, many pharmaceutical companies are assessing revenue models based on molecular diagnostics for pharmacogenomics testing.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the restraints to the growth of the Infectious Disease Molecular Diagnostics Market?

One of the key factors limiting the growth of the infectious disease molecular diagnostics market is inadequate reimbursements. The hurdles to getting Medicare insurance to pay for diagnostic tests are a significant concern for diagnostic organizations. In 2018, Medicare in the United States tightened constraints on I.V.D. diagnostic claims, which affected molecular diagnostic tests in particular. These molecular pathology tests might be billed using unlisted medical codes rather than the American Medical Association's Current Procedural Terminology (CPT) numbers. Medicare Administrative Contractors (MACs) set the allowable cost amount for the billing locality in these cases.

The entirety of the clinical lab will gradually be expected to execute molecular diagnostics testing on a regular basis. Venture capitalists, who formerly preferred not to make investments in this area, will progressively grow more enthusiastic about investing in molecular diagnostic businesses as the field of molecular diagnostics progresses.

Region-wise Insights

In what ways does the Infectious Disease Molecular Diagnostics Market in North America have a bright future?

The American Cancer Society estimates that there will be 1.7 Mn new instances of cancer in the US this year and more than 606 thousand cancer-related deaths. Therefore, it is predicted that over the forecast period, the demand for molecular diagnostics would expand due to the rising incidence of cancer and increased public awareness of the importance of early cancer detection. The development and global distribution agreement for molecular testing in Mexico to find new sexually-transmitted infections were announced by Becton Dickinson and Euroclone in February 2019. The market is projected to expand in the future due to rising diseases and innovation in North America.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Insights

United States Infectious Disease Molecular Diagnostics Market Analysis

The United States will account for over US$ 16.9 Bn of the global market by 2032. 6 out of 10 of America's adults have a chronic disease, and 4 out of 10 people have two or more diseases. , as of January 2021, according to a report made public by the National Center for Chronic Disease Prevention and Health Promotion. The US FDA had received emergency use authorization requests from Becton, Dickinson, and Company, and BioGX Inc. for novel diagnostic tests, the two businesses announced in March 2020.

U.K. Infectious Disease Molecular Diagnostics Market Analysis

The market in the U.K. is expected to reach US$ 2.2 Bn, growing from US$ 1.5 Bn in 2021.The market in the country is projected to expand at a CAGR of 3.5% during 2022 – 2032, and prosper with an absolute dollar opportunity of US$ 644 Mn.

Japan Infectious Disease Molecular Diagnostics Market Analysis

The market in Japan is expected to gross an absolute dollar opportunity of US$ 981 Mn during 2022 – 2032. During this period, the market is projected to register a CAGR of 5.9% to reach a market size of US$ 2.3 Bn by 2032.

South Korea Infectious Disease Molecular Diagnostics Market Analysis

The market in South Korea is expected to gross an absolute dollar opportunity of US$ 400 Mn during 2022 – 2032. The market is likely to reach a valuation of US$ 1.1 Bn by 2032.

Category-wise Insights

Why Polymerase Chain Reaction (PCR) segment dominates the Infectious Disease Molecular Diagnostics Technology Revenue?

The Polymerase Chain Reaction (PCR) segment account for over 30% of the technology category of the global Infectious Disease Molecular Diagnostics Market. The market growth from 2017-to 2021 was estimated at 4.4% CAGR. A qualitative outcome of a PCR investigation may be required for the detection of genetic polymorphisms, inherited disorders, somatic mutations, including cancer, and the presence of viral or microbial infections.

Quantitative PCR is increasingly needed, for instance, to assess a pathogen's "titer," the quantity of infected or altered cells in a tissue, and the concentration of particular mRNAs. PCR has several uses in medicine, including tissue typing for organ and tissue transplants. Commercially, HLA DQa locus analysis kits are currently readily available. The application of PCR for forensic purposes is associated with this application. The PCR can use this area, in particular, to take advantage of its extreme sensitivity.

Competitive Landscape

At present, many diagnostics firms that were under-represented in this area have sought partners or acquisitions to gain exposure, reflecting the growing interest in personalized medicine. The key companies operating in the market include F. Hoffmann-La Roche Ltd., Hologic, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Abbott Laboratories, bioMérieux SA, QIAGEN N.V., Myriad Genetics, Inc., Siemens Healthineers AG, Danaher Corporation, Illumina, Inc., Becton Dickinson and Company, Grifols, S.A., Quidel Corporation, Agilent Technologies, Inc., DiaSorin S.p.a. (Italy), Exact Sciences Corporation, Genetic Signatures, MDx Health, Biocartis NV, TBG Diagnostics Limited, HTG Molecular Diagnostics, Inc., Vela Diagnostics, Amoy Diagnostics Co., Ltd., ELITechGroup, Molbio Diagnostics Pvt. Ltd., Savyon Diagnostics, Abacus Diagnostica Oy, and geneOmbio Technologies Pvt. Ltd.

Some of the recent developments by key providers of the Infectious Disease Molecular Diagnostics are as follows:

  • In September 2021, F. Hoffmann-La Roche Ltd. announced the acquisition of TIB Molbiol to increase the breadth of infectious illness assays in its PCR test line.
  • In June 2021 Verogen and QIAGEN N.V. collaborated to increase the range of NGS technologies available.
  • In June 2021, Mobidiag Oy, a provider of acute care molecular diagnostic testing, was purchased by Hologic, Inc. The product offering for molecular diagnostics at Hologic will be boosted by this acquisition.
  • In November 2020, an additional FDA approval was given to Hologic, Inc. for the AptimaHIV-1 Quant Dx Assay's use in assisting with HIV infection diagnosis.

Similarly, recent developments related to companies manufacturing infectious disease molecular diagnostics kits have been tracked by the team at Future Market Insights, which is available in the full report.

Key Segments Covered in Infectious Disease Molecular Diagnostics Market Survey

By Technology:

  • Polymerase chain reaction (PCR)
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Chips and Microarrays
  • Mass Spectrometry
  • Sequencing
  • Others

By Product Type:

  • Instruments
  • Reagents
  • Services

By End Use:

  • Hospitals
  • Clinics
  • Diagnostics Laboratories
  • Research Institutes

By Application:

  • Respiratory Diseases
  • Tuberculosis
  • Meningitis
  • Gastrointestinal Tract Infections
  • HPV
  • Sexually Transmitted Infections
  • Sepsis
  • Drug Resistance Diseases
  • Other Infectious Diseases

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Frequently Asked Questions

The global Infectious Disease Molecular Diagnostics Market was valued at US$ 34 Bn in 2021.

The Infectious Disease Infectious Disease Molecular Diagnostics Market is set to witness a growth rate of 4.2% over the forecast period and be valued at US$ 53 Bn by 2032.

The Infectious Disease Infectious Disease Molecular Diagnostics Market expanded by 3.7% from 2017 through 2021.

The key players BD, BioMérieux SA, Bio-Rad Laboratories Inc., Abbott, and Agilent Technologies Inc. are shaping the Infectious Disease Molecular Diagnostics Market.

United States, United Kingdom, China, Japan, and South Korea are expected to drive the most sales growth in the Infectious Disease Molecular Diagnostics Market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. Value Chain Analysis

        3.5.1. Profit Margin Analysis

        3.5.2. Service Providers

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Bn) Analysis By Application, 2017-2021

    5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application, 2022-2032

        5.3.1. Oncology

            5.3.1.1. Breast Cancer

            5.3.1.2. Prostate Cancer

            5.3.1.3. Colorectal Cancer

            5.3.1.4. Cervical Cancer

            5.3.1.5. Kidney Cancer

            5.3.1.6. Liver Cancer

            5.3.1.7. Blood Cancer

            5.3.1.8. Lung Cancer

            5.3.1.9. Other Cancer

        5.3.2. Infectious Diseases

            5.3.2.1. Methicillin-resistant Staphylococcus Aureus (MRSA)

            5.3.2.2. Clostridium Difficile

            5.3.2.3. Vancomycin-resistant Enterococci (VRE)

            5.3.2.4. Carbapenem-resistant Bacteria

            5.3.2.5. Other Infectious Diseases

        5.3.3. Genetic Testing

            5.3.3.1. Newborn Screening

            5.3.3.2. Predictive and Presymptomatic Testing

            5.3.3.3. Other Genetic Testing

        5.3.4. Pharmacogenomics

        5.3.5. Neurological Disease

        5.3.6. Cardiovascular Disease

    5.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Application, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Bn) Analysis By Product Type, 2017-2021

    6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product Type, 2022-2032

        6.3.1. Instruments

        6.3.2. Reagents

        6.3.3. Other Product Types

    6.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Test Location

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Bn) Analysis By Test Location, 2017-2021

    7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Test Location, 2022-2032

        7.3.1. Point-of-Care

        7.3.2. Self-test or Over the Counter

        7.3.3. Central Laboratories

    7.4. Y-o-Y Growth Trend Analysis By Test Location, 2017-2021

    7.5. Absolute $ Opportunity Analysis By Test Location, 2022-2032

8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Technology

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Bn) Analysis By Technology , 2017-2021

    8.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Technology , 2022-2032

        8.3.1. Polymerase Chain Reaction (PCR)

        8.3.2. In Situ Hybridization (ISH)

        8.3.3. Isothermal Nucleic Acid Amplification Technology (INAAT)

        8.3.4. Chips and Microarrays

        8.3.5. Mass Spectrometry

        8.3.6. Sequencing

        8.3.7. Transcription Mediated Amplification (TMA)

        8.3.8. Other Technologies

    8.4. Y-o-Y Growth Trend Analysis By Technology , 2017-2021

    8.5. Absolute $ Opportunity Analysis By Technology , 2022-2032

9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2017-2021

    9.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2022-2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. MEA

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. U.S.

            10.2.1.2. Canada

        10.2.2. By Application

        10.2.3. By Product Type

        10.2.4. By Test Location

        10.2.5. By Technology

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Application

        10.3.3. By Product Type

        10.3.4. By Test Location

        10.3.5. By Technology

    10.4. Key Takeaways

11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Application

        11.2.3. By Product Type

        11.2.4. By Test Location

        11.2.5. By Technology

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Application

        11.3.3. By Product Type

        11.3.4. By Test Location

        11.3.5. By Technology

    11.4. Key Takeaways

12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. Italy

            12.2.1.3. France

            12.2.1.4. U.K.

            12.2.1.5. Spain

            12.2.1.6. Russia

            12.2.1.7. Rest of Europe

        12.2.2. By Application

        12.2.3. By Product Type

        12.2.4. By Test Location

        12.2.5. By Technology

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Application

        12.3.3. By Product Type

        12.3.4. By Test Location

        12.3.5. By Technology

    12.4. Key Takeaways

13. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. India

            13.2.1.4. South Korea

            13.2.1.5. Australia

            13.2.1.6. Rest of APAC

        13.2.2. By Application

        13.2.3. By Product Type

        13.2.4. By Test Location

        13.2.5. By Technology

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Application

        13.3.3. By Product Type

        13.3.4. By Test Location

        13.3.5. By Technology

    13.4. Key Takeaways

14. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. South Africa

            14.2.1.2. Saudi Arabia

            14.2.1.3. UAE

            14.2.1.4. Israel

            14.2.1.5. Rest of MEA

        14.2.2. By Application

        14.2.3. By Product Type

        14.2.4. By Test Location

        14.2.5. By Technology

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Application

        14.3.3. By Product Type

        14.3.4. By Test Location

        14.3.5. By Technology

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Application

            15.1.2.2. By Product Type

            15.1.2.3. By Test Location

            15.1.2.4. By Technology

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Application

            15.2.2.2. By Product Type

            15.2.2.3. By Test Location

            15.2.2.4. By Technology

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Application

            15.3.2.2. By Product Type

            15.3.2.3. By Test Location

            15.3.2.4. By Technology

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Application

            15.4.2.2. By Product Type

            15.4.2.3. By Test Location

            15.4.2.4. By Technology

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Application

            15.5.2.2. By Product Type

            15.5.2.3. By Test Location

            15.5.2.4. By Technology

    15.6. Italy

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Application

            15.6.2.2. By Product Type

            15.6.2.3. By Test Location

            15.6.2.4. By Technology

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Application

            15.7.2.2. By Product Type

            15.7.2.3. By Test Location

            15.7.2.4. By Technology

    15.8. U.K.

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Application

            15.8.2.2. By Product Type

            15.8.2.3. By Test Location

            15.8.2.4. By Technology

    15.9. Spain

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Application

            15.9.2.2. By Product Type

            15.9.2.3. By Test Location

            15.9.2.4. By Technology

    15.10. Russia

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Application

            15.10.2.2. By Product Type

            15.10.2.3. By Test Location

            15.10.2.4. By Technology

    15.11. China

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Application

            15.11.2.2. By Product Type

            15.11.2.3. By Test Location

            15.11.2.4. By Technology

    15.12. Japan

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Application

            15.12.2.2. By Product Type

            15.12.2.3. By Test Location

            15.12.2.4. By Technology

    15.13. India

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Application

            15.13.2.2. By Product Type

            15.13.2.3. By Test Location

            15.13.2.4. By Technology

    15.14. South Korea

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Application

            15.14.2.2. By Product Type

            15.14.2.3. By Test Location

            15.14.2.4. By Technology

    15.15. Australia

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Application

            15.15.2.2. By Product Type

            15.15.2.3. By Test Location

            15.15.2.4. By Technology

    15.16. South Africa

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Application

            15.16.2.2. By Product Type

            15.16.2.3. By Test Location

            15.16.2.4. By Technology

    15.17. Saudi Arabia

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Application

            15.17.2.2. By Product Type

            15.17.2.3. By Test Location

            15.17.2.4. By Technology

    15.18. UAE

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Application

            15.18.2.2. By Product Type

            15.18.2.3. By Test Location

            15.18.2.4. By Technology

    15.19. Israel

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Application

            15.19.2.2. By Product Type

            15.19.2.3. By Test Location

            15.19.2.4. By Technology

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Application

        16.3.3. By Product Type

        16.3.4. By Test Location

        16.3.5. By Technology

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. BD

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. BioMérieux SA

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Bio-Rad Laboratories Inc

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Abbott

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Agilent Technologies, Inc.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Danaher

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Hologic Inc

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. IlluminaInc

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Johnson & Johnson Services Inc

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. GrifolsS.A.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

        17.1.11. QIAGEN

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

                17.1.11.5.2. Product Strategy

                17.1.11.5.3. Channel Strategy

        17.1.12. F. Hoffmann-La RocheLtd

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

                17.1.12.5.2. Product Strategy

                17.1.12.5.3. Channel Strategy

        17.1.13. Siemens Healthineers AG

            17.1.13.1. Overview

            17.1.13.2. Product Portfolio

            17.1.13.3. Profitability by Market Segments

            17.1.13.4. Sales Footprint

            17.1.13.5. Strategy Overview

                17.1.13.5.1. Marketing Strategy

                17.1.13.5.2. Product Strategy

                17.1.13.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Bn) Forecast by Region, 2017-2032

Table 2: Global Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 3: Global Market Value (US$ Bn) Forecast by Product Type, 2017-2032

Table 4: Global Market Value (US$ Bn) Forecast by Test Location, 2017-2032

Table 5: Global Market Value (US$ Bn) Forecast by Technology , 2017-2032

Table 6: North America Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 7: North America Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 8: North America Market Value (US$ Bn) Forecast by Product Type, 2017-2032

Table 9: North America Market Value (US$ Bn) Forecast by Test Location, 2017-2032

Table 10: North America Market Value (US$ Bn) Forecast by Technology , 2017-2032

Table 11: Latin America Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 12: Latin America Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 13: Latin America Market Value (US$ Bn) Forecast by Product Type, 2017-2032

Table 14: Latin America Market Value (US$ Bn) Forecast by Test Location, 2017-2032

Table 15: Latin America Market Value (US$ Bn) Forecast by Technology , 2017-2032

Table 16: Europe Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 17: Europe Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 18: Europe Market Value (US$ Bn) Forecast by Product Type, 2017-2032

Table 19: Europe Market Value (US$ Bn) Forecast by Test Location, 2017-2032

Table 20: Europe Market Value (US$ Bn) Forecast by Technology , 2017-2032

Table 21: Asia Pacific Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 22: Asia Pacific Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 23: Asia Pacific Market Value (US$ Bn) Forecast by Product Type, 2017-2032

Table 24: Asia Pacific Market Value (US$ Bn) Forecast by Test Location, 2017-2032

Table 25: Asia Pacific Market Value (US$ Bn) Forecast by Technology , 2017-2032

Table 26: MEA Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 27: MEA Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 28: MEA Market Value (US$ Bn) Forecast by Product Type, 2017-2032

Table 29: MEA Market Value (US$ Bn) Forecast by Test Location, 2017-2032

Table 30: MEA Market Value (US$ Bn) Forecast by Technology , 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Bn) by Application, 2022-2032

Figure 2: Global Market Value (US$ Bn) by Product Type, 2022-2032

Figure 3: Global Market Value (US$ Bn) by Test Location, 2022-2032

Figure 4: Global Market Value (US$ Bn) by Technology , 2022-2032

Figure 5: Global Market Value (US$ Bn) by Region, 2022-2032

Figure 6: Global Market Value (US$ Bn) Analysis by Region, 2017-2032

Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 9: Global Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 10: Global Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 11: Global Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 12: Global Market Value (US$ Bn) Analysis by Product Type, 2017-2032

Figure 13: Global Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 14: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 15: Global Market Value (US$ Bn) Analysis by Test Location, 2017-2032

Figure 16: Global Market Value Share (%) and BPS Analysis by Test Location, 2022-2032

Figure 17: Global Market Y-o-Y Growth (%) Projections by Test Location, 2022-2032

Figure 18: Global Market Value (US$ Bn) Analysis by Technology , 2017-2032

Figure 19: Global Market Value Share (%) and BPS Analysis by Technology , 2022-2032

Figure 20: Global Market Y-o-Y Growth (%) Projections by Technology , 2022-2032

Figure 21: Global Market Attractiveness by Application, 2022-2032

Figure 22: Global Market Attractiveness by Product Type, 2022-2032

Figure 23: Global Market Attractiveness by Test Location, 2022-2032

Figure 24: Global Market Attractiveness by Technology , 2022-2032

Figure 25: Global Market Attractiveness by Region, 2022-2032

Figure 26: North America Market Value (US$ Bn) by Application, 2022-2032

Figure 27: North America Market Value (US$ Bn) by Product Type, 2022-2032

Figure 28: North America Market Value (US$ Bn) by Test Location, 2022-2032

Figure 29: North America Market Value (US$ Bn) by Technology , 2022-2032

Figure 30: North America Market Value (US$ Bn) by Country, 2022-2032

Figure 31: North America Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 34: North America Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 35: North America Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 37: North America Market Value (US$ Bn) Analysis by Product Type, 2017-2032

Figure 38: North America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 39: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 40: North America Market Value (US$ Bn) Analysis by Test Location, 2017-2032

Figure 41: North America Market Value Share (%) and BPS Analysis by Test Location, 2022-2032

Figure 42: North America Market Y-o-Y Growth (%) Projections by Test Location, 2022-2032

Figure 43: North America Market Value (US$ Bn) Analysis by Technology , 2017-2032

Figure 44: North America Market Value Share (%) and BPS Analysis by Technology , 2022-2032

Figure 45: North America Market Y-o-Y Growth (%) Projections by Technology , 2022-2032

Figure 46: North America Market Attractiveness by Application, 2022-2032

Figure 47: North America Market Attractiveness by Product Type, 2022-2032

Figure 48: North America Market Attractiveness by Test Location, 2022-2032

Figure 49: North America Market Attractiveness by Technology , 2022-2032

Figure 50: North America Market Attractiveness by Country, 2022-2032

Figure 51: Latin America Market Value (US$ Bn) by Application, 2022-2032

Figure 52: Latin America Market Value (US$ Bn) by Product Type, 2022-2032

Figure 53: Latin America Market Value (US$ Bn) by Test Location, 2022-2032

Figure 54: Latin America Market Value (US$ Bn) by Technology , 2022-2032

Figure 55: Latin America Market Value (US$ Bn) by Country, 2022-2032

Figure 56: Latin America Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 59: Latin America Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 60: Latin America Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 62: Latin America Market Value (US$ Bn) Analysis by Product Type, 2017-2032

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 65: Latin America Market Value (US$ Bn) Analysis by Test Location, 2017-2032

Figure 66: Latin America Market Value Share (%) and BPS Analysis by Test Location, 2022-2032

Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Test Location, 2022-2032

Figure 68: Latin America Market Value (US$ Bn) Analysis by Technology , 2017-2032

Figure 69: Latin America Market Value Share (%) and BPS Analysis by Technology , 2022-2032

Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Technology , 2022-2032

Figure 71: Latin America Market Attractiveness by Application, 2022-2032

Figure 72: Latin America Market Attractiveness by Product Type, 2022-2032

Figure 73: Latin America Market Attractiveness by Test Location, 2022-2032

Figure 74: Latin America Market Attractiveness by Technology , 2022-2032

Figure 75: Latin America Market Attractiveness by Country, 2022-2032

Figure 76: Europe Market Value (US$ Bn) by Application, 2022-2032

Figure 77: Europe Market Value (US$ Bn) by Product Type, 2022-2032

Figure 78: Europe Market Value (US$ Bn) by Test Location, 2022-2032

Figure 79: Europe Market Value (US$ Bn) by Technology , 2022-2032

Figure 80: Europe Market Value (US$ Bn) by Country, 2022-2032

Figure 81: Europe Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 84: Europe Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 85: Europe Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 86: Europe Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 87: Europe Market Value (US$ Bn) Analysis by Product Type, 2017-2032

Figure 88: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 89: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 90: Europe Market Value (US$ Bn) Analysis by Test Location, 2017-2032

Figure 91: Europe Market Value Share (%) and BPS Analysis by Test Location, 2022-2032

Figure 92: Europe Market Y-o-Y Growth (%) Projections by Test Location, 2022-2032

Figure 93: Europe Market Value (US$ Bn) Analysis by Technology , 2017-2032

Figure 94: Europe Market Value Share (%) and BPS Analysis by Technology , 2022-2032

Figure 95: Europe Market Y-o-Y Growth (%) Projections by Technology , 2022-2032

Figure 96: Europe Market Attractiveness by Application, 2022-2032

Figure 97: Europe Market Attractiveness by Product Type, 2022-2032

Figure 98: Europe Market Attractiveness by Test Location, 2022-2032

Figure 99: Europe Market Attractiveness by Technology , 2022-2032

Figure 100: Europe Market Attractiveness by Country, 2022-2032

Figure 101: Asia Pacific Market Value (US$ Bn) by Application, 2022-2032

Figure 102: Asia Pacific Market Value (US$ Bn) by Product Type, 2022-2032

Figure 103: Asia Pacific Market Value (US$ Bn) by Test Location, 2022-2032

Figure 104: Asia Pacific Market Value (US$ Bn) by Technology , 2022-2032

Figure 105: Asia Pacific Market Value (US$ Bn) by Country, 2022-2032

Figure 106: Asia Pacific Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 109: Asia Pacific Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 112: Asia Pacific Market Value (US$ Bn) Analysis by Product Type, 2017-2032

Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 115: Asia Pacific Market Value (US$ Bn) Analysis by Test Location, 2017-2032

Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Test Location, 2022-2032

Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Test Location, 2022-2032

Figure 118: Asia Pacific Market Value (US$ Bn) Analysis by Technology , 2017-2032

Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by Technology , 2022-2032

Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology , 2022-2032

Figure 121: Asia Pacific Market Attractiveness by Application, 2022-2032

Figure 122: Asia Pacific Market Attractiveness by Product Type, 2022-2032

Figure 123: Asia Pacific Market Attractiveness by Test Location, 2022-2032

Figure 124: Asia Pacific Market Attractiveness by Technology , 2022-2032

Figure 125: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 126: MEA Market Value (US$ Bn) by Application, 2022-2032

Figure 127: MEA Market Value (US$ Bn) by Product Type, 2022-2032

Figure 128: MEA Market Value (US$ Bn) by Test Location, 2022-2032

Figure 129: MEA Market Value (US$ Bn) by Technology , 2022-2032

Figure 130: MEA Market Value (US$ Bn) by Country, 2022-2032

Figure 131: MEA Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 132: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 133: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 134: MEA Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 135: MEA Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 136: MEA Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 137: MEA Market Value (US$ Bn) Analysis by Product Type, 2017-2032

Figure 138: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 139: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 140: MEA Market Value (US$ Bn) Analysis by Test Location, 2017-2032

Figure 141: MEA Market Value Share (%) and BPS Analysis by Test Location, 2022-2032

Figure 142: MEA Market Y-o-Y Growth (%) Projections by Test Location, 2022-2032

Figure 143: MEA Market Value (US$ Bn) Analysis by Technology , 2017-2032

Figure 144: MEA Market Value Share (%) and BPS Analysis by Technology , 2022-2032

Figure 145: MEA Market Y-o-Y Growth (%) Projections by Technology , 2022-2032

Figure 146: MEA Market Attractiveness by Application, 2022-2032

Figure 147: MEA Market Attractiveness by Product Type, 2022-2032

Figure 148: MEA Market Attractiveness by Test Location, 2022-2032

Figure 149: MEA Market Attractiveness by Technology , 2022-2032

Figure 150: MEA Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Poultry Diagnostics Market

Published : November 2020

Healthcare

Molecular Diagnostics Market

Published : February 2016

Healthcare

Infectious Disease Diagnostics Market

Published : January 2016

Healthcare

Tissue Diagnostics Market

Published : July 2020

Google translate

Infectious Diseases Molecular Diagnostics Market